Last updated on February 2018

Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Postpartum Anemia
  • Age: Between 18 - 45 Years
  • Gender: Female

Inclusion Criteria:

  1. Women aged 18 years to 45 years with mild postpartum anemia (Hb <10 g/dl and 7 g/dl at 24-48 hours postpartum);
  2. Absence of antepartum anemia, which is defined as Hb11.0 g/dL within 48 hours before delivery;
  3. Singleton pregnancy;
  4. Type of syndrome in Traditional Chinese Medicine is "Qi-blood deficiency".
  5. Patients having not received blood transfusion or any forms of anti-anemia treatment in Western medicine or TCM in the last 12 weeks;
  6. Informed consent obtained.

Exclusion Criteria:

  1. Type of syndrome in TCM is NOT "Qi-blood deficiency";
  2. Antepartum anemia;
  3. Twin or multiple pregnancies;
  4. A history of haematological disease (e.g. sickle cell anemia or thalassemias);
  5. A history of undigestive disease (e.g. gastric ulcer, gastritis) or inflammatory bowel disease;
  6. A history of cardiovascular diseases, renal or liver disease, asthma, thromboembolism, HIV infection, tuberculosis, cancer and seizures;
  7. Patients having received blood transfusion or any forms of anti-anemia treatment in Western medicine or TCM in the last 12 weeks;
  8. Alcohol or drug abuse;
  9. Patients with mental illness or poor compliance to medical treatment;
  10. Participation in another clinical trial within the previous three months;
  11. No informed consent obtained.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.